| 1K5M | C:1628-1797; C:1628-1797 | CRYSTAL STRUCTURE OF A HUMAN RHINOVIRUS TYPE 14:HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 V3 LOOP CHIMERIC VIRUS MN-III-2 |
| 1NA1 | C:28-197; C:28-197; C:28-197 | THE STRUCTURE OF HRV14 WHEN COMPLEXED WITH PLECONARIL |
| 1NCQ | C:28-197; C:28-197; C:28-197 | THE STRUCTURE OF HRV14 WHEN COMPLEXED WITH PLECONARIL, AN ANTIVIRAL COMPOUND |
| 1R09 | 3:28-197; 3:28-197; 3:28-197 | HUMAN RHINOVIRUS 14 COMPLEXED WITH ANTIVIRAL COMPOUND R 61837 |
| 1RMU | 3:28-197; 3:28-197; 3:28-197 | THREE-DIMENSIONAL STRUCTURES OF DRUG-RESISTANT MUTANTS OF HUMAN RHINOVIRUS 14 |
| 1RUC | 3:28-197; 3:28-197; 3:28-197 | RHINOVIRUS 14 MUTANT N1105S COMPLEXED WITH ANTIVIRAL COMPOUND WIN 52035 |
| 1RUD | 3:28-197; 3:28-197; 3:28-197 | RHINOVIRUS 14 MUTANT N1105S COMPLEXED WITH ANTIVIRAL COMPOUND WIN 52084 |
| 1RUE | 3:28-197; 3:28-197; 3:28-197 | RHINOVIRUS 14 SITE DIRECTED MUTANT N1219A COMPLEXED WITH ANTIVIRAL COMPOUND WIN 52035 |
| 1RUF | 3:28-197; 3:28-197; 3:28-197 | RHINOVIRUS 14 (HRV14) (MUTANT WITH ASN 1 219 REPLACED BY ALA (N219A IN CHAIN 1) |
| 1RUH | 3:28-197; 3:28-197; 3:28-197 | RHINOVIRUS 14 MUTANT N1219S COMPLEXED WITH ANTIVIRAL COMPOUND WIN 52084 |
| 1RUI | 3:28-197; 3:28-197; 3:28-197 | RHINOVIRUS 14 MUTANT S1223G COMPLEXED WITH ANTIVIRAL COMPOUND WIN 52084 |
| 1RUJ | 3:28-197; 3:28-197; 3:28-197 | RHINOVIRUS 14 MUTANT WITH SER 1 223 REPLACED BY GLY (S1223G) |
| 1VRH | 3:28-197; 3:28-197; 3:28-197 | HRV14/SDZ 880-061 COMPLEX |
| 2R06 | 3:28-197; 3:28-197; 3:28-197 | STRUCTURAL ANALYSIS OF ANTIVIRAL AGENTS THAT INTERACT WITH THE CAPSID OF HUMAN RHINOVIRUSES |
| 2R07 | 3:28-197; 3:28-197; 3:28-197 | STRUCTURAL ANALYSIS OF ANTIVIRAL AGENTS THAT INTERACT WITH THE CAPSID OF HUMAN RHINOVIRUSES |
| 2RMU | 3:28-197; 3:28-197; 3:28-197 | THREE-DIMENSIONAL STRUCTURES OF DRUG-RESISTANT MUTANTS OF HUMAN RHINOVIRUS 14 |
| 2RR1 | 3:28-197; 3:28-197; 3:28-197 | STRUCTURAL ANALYSIS OF ANTIVIRAL AGENTS THAT INTERACT WITH THE CAPSID OF HUMAN RHINOVIRUSES |
| 2RS1 | 3:28-197; 3:28-197; 3:28-197 | STRUCTURAL ANALYSIS OF ANTIVIRAL AGENTS THAT INTERACT WITH THE CAPSID OF HUMAN RHINOVIRUSES |
| 2RS3 | 3:28-197; 3:28-197; 3:28-197 | STRUCTURAL ANALYSIS OF ANTIVIRAL AGENTS THAT INTERACT WITH THE CAPSID OF HUMAN RHINOVIRUSES |
| 2RS5 | 3:28-197; 3:28-197; 3:28-197 | STRUCTURAL ANALYSIS OF ANTIVIRAL AGENTS THAT INTERACT WITH THE CAPSID OF HUMAN RHINOVIRUSES |